ISVHLD

AcronymDefinition
ISVHLDInternational Symposium on Viral Hepatitis and Liver Disease
References in periodicals archive ?
May 14 /PRNewswire/ -- ImQuest Bio and Arisyn jointly presented important new results on ATI-0810 (Formerly PG301029), a novel late stage inhibitor of hepatitis C virus (HCV) replication, at the 13th ISVHLD meeting held last week in Washington D.
Data further characterizing the resistance profile of Hepsera also were presented today at ISVHLD by Stephen Locarnini, MD, Divisional Head of Research and Molecular Development, Victorian Infectious Diseases Reference Laboratory, Melbourne, Australia (Presentation 779).